Literature DB >> 15604442

In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2.

B Precious1, D F Young1, L Andrejeva1, S Goodbourn2, R E Randall1.   

Abstract

Previous work has documented that the V protein of simian virus 5 (SV5) targets STAT1 for proteasome-mediated degradation, whilst the V protein of human parainfluenza virus type 2 (hPIV2) targets STAT2. Here, it was shown that the processes of ubiquitination and degradation could be reconstructed in vitro by using programmed rabbit reticulocyte lysates. Using this system, the addition of bacterially expressed and purified SV5 V protein to programmed lysates was demonstrated to result in the polyubiquitination and degradation of in vitro-translated STAT1, but only if human STAT2 was also present. Surprisingly, in the same assay, purified hPIV2 V protein induced the polyubiquitination of both STAT1 and STAT2. In the light of these in vitro results, the specificity of degradation of STAT1 and STAT2 by SV5 and hPIV2 in tissue-culture cells was re-examined. As previously reported, STAT1 could not be detected in human cells that expressed SV5 V protein constitutively, whilst STAT2 could not be detected in human cells that expressed hPIV2 V protein, although the levels of STAT1 may also have been reduced in some human cells infected with hPIV2. In contrast, STAT1 could not be detected, whereas STAT2 remained present, in a variety of animal cells, including canine (MDCK) cells, that expressed the V protein of either SV5 or hPIV2. Thus, the V protein of SV5 appears to be highly specific for STAT1 degradation, but the V protein of hPIV2 is more promiscuous.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15604442     DOI: 10.1099/vir.0.80263-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

Review 1.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

2.  Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling.

Authors:  Benjamin G Hale; David Jackson; Yun-Hsiang Chen; Robert A Lamb; Richard E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

3.  Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.

Authors:  Christina M Ulane; Alex Kentsis; Cristian D Cruz; Jean-Patrick Parisien; Kristi L Schneider; Curt M Horvath
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.

Authors:  Anne Schaap-Nutt; Margaret A Scull; Alexander C Schmidt; Brian R Murphy; Raymond J Pickles
Journal:  Vaccine       Date:  2010-02-20       Impact factor: 3.641

5.  Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs.

Authors:  K Hagmaier; N Stock; B Precious; K Childs; L-F Wang; S Goodbourn; R E Randall
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

6.  Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.

Authors:  Samer Swedan; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting.

Authors:  Mamta Puri; Ken Lemon; W Paul Duprex; Bertus K Rima; Curt M Horvath
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

8.  Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.

Authors:  Raychel Chambers; Toru Takimoto
Journal:  J Gen Virol       Date:  2009-05-07       Impact factor: 3.891

9.  The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling.

Authors:  Kim G Lieu; Aaron Brice; Linda Wiltzer; Bevan Hirst; David A Jans; Danielle Blondel; Gregory W Moseley
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

10.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.